Search the collection

90 results for VEGFR2/KDR

Sort by:

Sort by

Limit results to:

20 per page

90 results for VEGFR2/KDR

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
CRISPR‐mediated knockout of VEGFR2/KDR inhibits cell growth in a squamous thyroid cancer cell line
Author / Creator:Tsai, Ming‐Lin ; Lee, Chia‐Hwa ; Huang, Li‐Chi ; Chen, Yu‐Hsin ; Liu, Wei‐Ni ; Lin, Chun‐Yu ; Hsu, Kai‐Wen ; Lee, Ai‐Wei ; Lin, Ching‐Ling
Publisher:England: John Wiley & Sons, Inc
Journal title:FEBS open bio, 2022-05, Vol.12 (5), p.993-1005
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR antibody Delivery of sodium morrhuate to hemangioma endothelial cells using immunolip...
Author / Creator:Li XL ; Ren XY ; Liang JM ; Ma WJ ; Wang ZH ; Yang ZQ
Publisher:Dove Medical Press
Journal title:International journal of nanomedicine, 2017-09, Vol.12, p.6963-6972
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR antibody
Author / Creator:Li, Xiaoli ; Ren, Xiaoyong ; Liang, Jianmin ; Ma, Weijun ; Wang, Zhenghui ; Yang, Zhuangqun
Publisher:New Zealand: Dove Medical Press Limited
Journal title:International journal of nanomedicine, 2017-01, Vol.12, p.6963-6972
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Tumor Specific VEGF-A and VEGFR2/KDR Protein are Co-expressed in Breast Cancer
Author / Creator:Rydén, Lisa ; Linderholm, Barbro ; Nielsen, Niels Hilmer ; Emdin, Stefan ; Jönsson, Per-Ebbe ; Landberg, Göran
Publisher:Dordrecht: Springer
Journal title:Breast cancer research and treatment, 2003-12, Vol.82 (3), p.147-154
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit
Author / Creator:Wu, Chunjiang ; Wang, Min ; Tang, Qidong ; Luo, Rong ; Chen, Le ; Zheng, Pengwu ; Zhu, Wufu
Publisher:Switzerland: MDPI AG
Journal title:Molecules (Basel, Switzerland), 2015-10, Vol.20 (10), p.19361-19371
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
402. Modified AAV1-Based Vectors Targeted to VEGFR2/KDR Mediate Increased Gene Transfer to Proliferating Vascular Endothelial Cells and Tumor-Associated Neovasculture
Publisher:Elsevier Inc
Journal title:Molecular therapy, 2009-05, Vol.17, p.S157-S158
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Exacerbation of Diabetic Retinopathy by Hypertension May Be Mediated by Stretch-Induced VEGFR2/KDR Expression
Author / Creator:AIELLO, LLOYD PAUL ; SUZUMA, IZUMI ; HATA, YASUAKI ; ROOK, SUSAN ; SUZUMA, KIYOSHI ; FEENER, EDWARD
Publisher:American Diabetes Association
Journal title:Diabetes (New York, N.Y.), 2000-05, Vol.49 (5), p.A49
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesFull Text
Researchers from Translational Research Institute Describe Findings in Hematopoietic Stem Cell Mobilization (HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilizatio...
Publisher:NewsRX LLC
Journal title:Stem cell week, 2019-02, p.4363
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesFull Text
New Findings Reported from Xi'an Jiaotong University Describe Advances in Liposomes (Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR...
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2017-10, p.3467
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
Newsletter articlesFull Text
3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine: Tanibirumab is a novel VEGFR2-neutralizing mAb for treating cancers
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2014
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model
Author / Creator:Zhang, Wei ; Ran, Sophia ; Sambade, M. ; Huang, Xianming ; Thorpe, Philip E.
Publisher:Dordrecht: Springer
Journal title:Angiogenesis (London), 2002, Vol.5 (1-2), p.35-44
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2
Author / Creator:Xie, Wei ; Li, Daojuan ; Zhang, Juan ; Li, Zhike ; Acheampong, Desmond Omane ; He, Yuan ; Wang, Youfu ; Chen, Zhiguo ; Wang, Min
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Cancer Immunology, Immunotherapy, 2014-09, Vol.63 (9), p.877-888
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
Newsletter articlesFull Text
Pharmabcine Inc Submits WIPO Patent Application for Fusion Protein Comprising Modified Anti-VEGFR2 (KDR) Antibody and Use Thereof
Publisher:New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title:Global IP News. Pharmaceutical Patent News, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
Newsletter articlesFull Text
European Patent Office Publishes Pharmabcine Inc's Patent Application for Modified Anti-VEGFR2 (KDR) Antibody and Use Thereof
Publisher:New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title:Global IP News. Pharmaceutical Patent News, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesPeer ReviewedFull Text
Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma
Author / Creator:Misawa, Yuki ; Misawa, Kiyoshi ; Kawasaki, Hideya ; Imai, Atsushi ; Mochizuki, Daiki ; Ishikawa, Ryuji ; Endo, Shiori ; Mima, Masato ; Kanazawa, Takeharu ; Iwashita, Toshihide ; Mineta, Hiroyuki
Publisher:London, England: SAGE Publications
Journal title:Tumor biology, 2017-07, Vol.39 (7), p.101042831771165-1010428317711657
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
Newsletter articlesFull Text
INTERNATIONAL PATENT: PHARMABCINE INC. FILES APPLICATION FOR "MODIFIED ANTI-VEGFR2 (KDR) ANTIBODY AND USE THEREOF"
Publisher:Washington, D.C: HT Digital Streams Limited
Journal title:US Fed News Service, Including US State News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
Newsletter articlesFull Text
World Intellectual Property Organization Releases Pharmabcine Inc's Patent Application for Fusion Protein Comprising Modified Anti-VEGFR2 (KDR) Antibody and Use Thereof
Publisher:New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title:Global IP News. Pharmaceutical Patent News, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
Newsletter articlesFull Text
INTERNATIONAL PATENT: PHARMABCINE INC., 주식회사 파멥신 FILES APPLICATION FOR "FUSION PROTEIN COMPRISING MODIFIED ANTI-VEGFR2(KDR) ANTIBODY AND USE THEREOF"
Publisher:Washington, D.C: HT Digital Streams Limited
Journal title:US Fed News Service, Including US State News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesPeer ReviewedFull Text
Internalization of Vectored Liposomes in a Culture of Poorly Differentiated Tumor Cells
Author / Creator:Mel’nikov, P. A. ; Baklaushev, V. P. ; Gabashvili, A. N. ; Nukolova, N. V. ; Levinsky, A. B. ; Chehonin, V. P.
Publisher:New York: Springer US
Journal title:Bulletin of experimental biology and medicine, 2016-08, Vol.161 (4), p.593-599
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
Newsletter articlesFull Text
INTERNATIONAL PATENT: PHARMABCINE INC., 주식회사 파멥신 FILES APPLICATION FOR "FUSION PROTEIN COMPRISING MODIFIED ANTI-VEGFR2 (KDR) ANTIBODY AND USE THEREOF"
Publisher:Washington, D.C: HT Digital Streams Limited
Journal title:US Fed News Service, Including US State News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 90 results

Export record to excel

Export this record

Export record to excel

CRISPR‐mediated knockout of VEGFR2/KDR inhibits cell growth in a squamous thyroid cancer cell line

Export this record

Export record to excel

Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR antibody Delivery of sodium morrhuate to hemangioma endothelial cells using immunolip...

Export this record

Export record to excel

Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR antibody

Export this record

Export record to excel

Tumor Specific VEGF-A and VEGFR2/KDR Protein are Co-expressed in Breast Cancer

Export this record

Export record to excel

Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit

Export this record

Export record to excel

402. Modified AAV1-Based Vectors Targeted to VEGFR2/KDR Mediate Increased Gene Transfer to Proliferating Vascular Endothelial Cells and Tumor-Associated Neovasculture

Export this record

Export record to excel

Exacerbation of Diabetic Retinopathy by Hypertension May Be Mediated by Stretch-Induced VEGFR2/KDR Expression

Export this record

Export record to excel

Researchers from Translational Research Institute Describe Findings in Hematopoietic Stem Cell Mobilization (HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilizatio...

Export this record

Export record to excel

New Findings Reported from Xi'an Jiaotong University Describe Advances in Liposomes (Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR...

Export this record

Export record to excel

3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine: Tanibirumab is a novel VEGFR2-neutralizing mAb for treating cancers

Export this record

Export record to excel

A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model

Export this record

Export record to excel

Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2

Export this record

Export record to excel

Pharmabcine Inc Submits WIPO Patent Application for Fusion Protein Comprising Modified Anti-VEGFR2 (KDR) Antibody and Use Thereof

Export this record

Export record to excel

European Patent Office Publishes Pharmabcine Inc's Patent Application for Modified Anti-VEGFR2 (KDR) Antibody and Use Thereof

Export this record

Export record to excel

Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma

Export this record

Export record to excel

INTERNATIONAL PATENT: PHARMABCINE INC. FILES APPLICATION FOR "MODIFIED ANTI-VEGFR2 (KDR) ANTIBODY AND USE THEREOF"

Export this record

Export record to excel

World Intellectual Property Organization Releases Pharmabcine Inc's Patent Application for Fusion Protein Comprising Modified Anti-VEGFR2 (KDR) Antibody and Use Thereof

Export this record

Export record to excel

INTERNATIONAL PATENT: PHARMABCINE INC., 주식회사 파멥신 FILES APPLICATION FOR "FUSION PROTEIN COMPRISING MODIFIED ANTI-VEGFR2(KDR) ANTIBODY AND USE THEREOF"

Export this record

Export record to excel

Internalization of Vectored Liposomes in a Culture of Poorly Differentiated Tumor Cells

Export this record

Export record to excel

INTERNATIONAL PATENT: PHARMABCINE INC., 주식회사 파멥신 FILES APPLICATION FOR "FUSION PROTEIN COMPRISING MODIFIED ANTI-VEGFR2 (KDR) ANTIBODY AND USE THEREOF"

Refine your search